Drug Class
Targeted Cancer Therapy
18 generics
Axitinib
Renal cell carcinoma
2
brands
Bevacizumab
Wet age-related macular degeneration
12
brands
Bortezomib
Multiple myeloma
5
brands
Cetuximab
Head & neck cancer
2
brands
Crizotinib
Metastatic non-small cell lung cancer
7
brands
Dasatinib
Chronic myeloid leukaemia
15
brands
Eribulin Mesylate
Metastatic breast carcinoma
2
brands
Erlotinib
Pancreatic cancer
18
brands
Gefitinib
Non-small cell lung cancer
8
brands
Ibrutinib
Waldenström's macroglobulinemia
9
brands
Imatinib Mesylate
25
brands
Infliximab
Ulcerative colitis
2
brands
Nilotinib
Leukemia
6
brands
Olaparib
Ovarian cancer
18
brands
Pertuzumab
Breast cancer
2
brands
Regorafenib
Hepatocellular Carcinoma
6
brands
Sorafenib Tosylate
Renal cell carcinoma
10
brands
Sunitinib
Renal cell carcinoma
4
brands